KNSA

Moat Ross

Known title: CHIEF OPERATING OFFICERCIK: 0001857177

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Kiniksa Reports Strong Growth and Accelerating Earnings. Kiniksa Pharmaceuticals has reported earnings that are accelerating, supporting its growth narrative. Analysts note that the company’s performance shows little room for disappointment, reinforcing confidence in its business model. The company’s recent data underscores its position as a solid growth player in the pharmaceutical sector.

Transaction History

KNSA▲ Buy—
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▼ Sell$318K
KNSA▲ Buy—
KNSA▼ Sell$80K
KNSA▼ Sell$38K
KNSA▲ Buy—
KNSA▼ Sell$115K
KNSA▼ Sell$82K
KNSA▲ Buy—
KNSA▲ Buy$21K
KNSA▼ Sell$124K
KNSA▼ Sell$16K
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▼ Sell$94K
KNSA▲ Buy$368K
KNSA▼ Sell$801K
KNSA▲ Buy$111K
KNSA▼ Sell$176K
KNSA▲ Buy$68K
KNSA▼ Sell$108K
KNSA▲ Buy$179K
KNSA▲ Buy$96K
KNSA▲ Buy$21K
KNSA▼ Sell$651K
KNSA▲ Buy$233K
KNSA▲ Buy$310K
KNSA▲ Buy$82K
KNSA▲ Buy$89K
KNSA▲ Buy$165K
KNSA▼ Sell$1.6M
KNSA▼ Sell$370K
KNSA▲ Buy—
KNSA▼ Sell$15K
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▼ Sell$10K
KNSA▼ Sell$11K
KNSA▲ Buy—
KNSA▼ Sell$7K
KNSA▲ Buy$18K
KNSA▲ Buy$124K
KNSA▲ Buy$297K
KNSA▲ Buy$330K
KNSA▼ Sell$1.8M
KNSA▼ Sell$31K
KNSA▲ Buy—
KNSA▼ Sell$9K
KNSA▲ Buy—
KNSA▼ Sell$37K
KNSA▲ Buy$3K
KNSA▲ Buy—
KNSA▼ Sell$24K
KNSA▲ Buy—
KNSA▼ Sell$17K
KNSA▲ Buy—
KNSA▼ Sell$10K
KNSA▲ Buy—
KNSA▼ Sell$24K
KNSA▲ Buy$4K
KNSA▼ Sell$14K
KNSA▲ Buy—
KNSA▲ Buy—
KNSA▼ Sell$13K
KNSA▲ Buy—
KNSA▼ Sell$6K
KNSA▲ Buy$18K
KNSA▲ Buy—
KNSA▼ Sell$6K
KNSA▲ Buy$3K
KNSA▲ Buy—
KNSA▼ Sell$14K
KNSA▲ Buy—
KNSA▼ Sell$6K
KNSA▲ Buy$15K
KNSA▲ Buy$11K

We use analytics to understand how market-wall is used. No personal data is sold.